Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
AllChemie, Arch, assist, Bird, broker, brokerage, categorized, chairman, complaint, Cooperation, corroborated, difficulty, doubt, embedded, exit, fallen, flat, fractional, Hedging, hierarchy, Hill, instrument, Jeffrey, lieu, lowest, melanoma, nonfinancial, occasioned, odd, orderly, par, pemetrexed, procuring, proportion, reclassification, reclassifying, recurring, sentiment, Sutter, team, Treaty, tumorsclinical, unobservable, vessel
Filing tables
Filing exhibits
- 10-K Annual report
- 3.4 Certificate of Amendment of the Amended & Restated Certificate of Incorporation
- 23.1 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification Pursuant to Rule 15D-14
- 31.2 Certification Pursuant to Rule 15D-14
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification Pursuant to 18 U.s.c. Section 1350
Related press release
MTEM similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-153475) and Registration Statement on Form S-8 (No. 333-156733, No. 333-126276, No. 333-134598, and No. 333-143130) of Threshold Pharmaceuticals, Inc. of our report dated March 13, 2009 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 13, 2009